文献速递肝胆胰外科围术期管理与 ERAS

微创与开放远端胰腺切除术的成本与生活质量随机试验比较(LEOPARD试验)

Costs and quality of life in a randomized trial comparing minimally invasive and open distal pancreatectomy (LEOPARD trial).
PubMed 文献 · Br J Surg · 2019-04-23

LEOPARD试验在14家荷兰中心将患者随机分配至微创或开放远端胰腺切除术,记录术后1年内医疗资源使用、并发症及疾病特异性生活质量。104例患者中48例微创、56例开放,机器人辅助病例被排除在成本分析外。腹腔镜与开放远端胰腺切除术总医疗成本相当(均差€-427,95%CI €-4700至3613;

要点

  • 微创与开放组术后1年美观满意度和疾病特异性生活质量无显著差异。

核心结论

  • 腹腔镜远端胰腺切除术在功能恢复时间和质量调整生命年方面至少与开放手术具有同等成本效果。
  • 微创与开放远端胰腺切除术术后1年美观满意度和生活质量相似。

研究设计与样本

  • LEOPARD试验为随机对照试验,2015年4月至2017年3月在14家荷兰中心纳入患者。
  • 患者随机分配至微创(机器人辅助或腹腔镜)或开放远端胰腺切除术。
  • 共104例接受远端胰腺切除术患者纳入分析(48例微创,56例开放),机器人辅助病例被排除在成本分析外。
  • 记录术后1年内医院医疗资源使用、并发症及疾病特异性生活质量,进行成本效果和成本效用分析。

主要发现

  • 微创与开放远端胰腺切除术术后疾病特异性生活质量无显著差异。

临床怎么用

  • 腹腔镜远端胰腺切除术可作为开放手术的替代方案,在功能恢复和成本效果方面至少不劣于开放手术。
  • 术后1年美观满意度和生活质量两组相似,选择术式时可综合考虑其他临床因素。

局限性

  • 机器人辅助远端胰腺切除术病例被排除在成本分析外,可能限制结果对所有微创术式的推广。
  • 成本效果概率分析基于支付意愿阈值假设,实际应用需结合当地医疗经济环境。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Minimally invasive distal pancreatectomy decreases time to functional recovery compared with open distal pancreatectomy, but the cost-effectiveness and impact on disease-specific quality of life have yet to be established. METHODS: The LEOPARD trial randomized patients to minimally invasive (robot-assisted or laparoscopic) or open distal pancreatectomy in 14 Dutch centres between April 2015 and March 2017. Use of hospital healthcare resources, complications and disease-specific quality of life were recorded up to 1 year after surgery. Unit costs of hospital healthcare resources were determined, and cost-effectiveness and cost-utility analyses were performed. Primary outcomes were the costs per day earlier functional recovery and per quality-adjusted life-year. RESULTS: All 104 patients who had a distal pancreatectomy (48 minimally invasive and 56 open) in the trial were included in this study. Patients who underwent a robot-assisted procedure were excluded from the cost analysis. Total medical costs were comparable after laparoscopic and open distal pancreatectomy (mean difference €-427 (95 per cent bias-corrected and accelerated confidence interval €-4700 to 3613; P = 0·839). Laparoscopic distal pancreatectomy was shown to have a probability of at least 0·566 of being more cost-effective than the open approach at a willingness-to-pay threshold of €0 per day of earlier recovery, and a probability of 0·676 per additional quality-adjusted life-year at a willingness-to-pay threshold of €80 000. There were no significant differences in cosmetic satisfaction scores (median 9 (i.q.r. 5·75-10) versus 7 (4-8·75); P = 0·056) and disease-specific quality of life after minimally invasive (laparoscopic and robot-assisted procedures) versus open distal pancreatectomy. CONCLUSION: Laparoscopic distal pancreatectomy was at least as cost-effective as open distal pancreatectomy in terms of time to functional recovery and quality-adjusted life-years. Cosmesis and quality of life were similar in the two groups 1 year after surgery.

来源:Br J Surg,查看原文。版权归原作者所有。

引用

  1. van Hilst J, Strating EA, de Rooij T, et al. Costs and quality of life in a randomized trial comparing minimally invasive and open distal pancreatectomy (LEOPARD trial). Br J Surg. 2019. PMID: 31012498. doi:10.1002/bjs.11147

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。